Nomogram Predicts Osteoporosis Risk in Rheumatoid Arthritis Patients
This single-center retrospective study developed a nomogram prediction model for osteoporosis risk in rheumatoid arthritis (RA) patients. The study included 349 RA patients with available dual-energy X-ray absorptiometry (DXA) data. The overall prevalence of osteoporosis was 37.8% (132/349). In the training cohort (n=250), prevalence was 36.8% (92/250), and in the validation cohort (n=99), it was 40.4% (40/99).
Independent predictors of osteoporosis identified were female sex, higher Health Assessment Questionnaire Disability Index (HAQ-DI), elevated alkaline phosphatase (ALP), increased apolipoprotein A1/apolipoprotein B (ApoA1/ApoB) ratio, higher free fatty acids (FFA), and lower body mass index (BMI). The model demonstrated good discrimination with an area under the receiver operating characteristic curve (AUROC) of 0.812 in the training set and 0.788 in the validation set. Calibration was adequate (Hosmer-Lemeshow test p > 0.05). Decision curve analysis and risk stratification showed statistically significant odds ratios for medium and high-risk groups.
Safety and tolerability were not reported as this was a prediction model study without interventions. Key limitations include the model's unknown performance in diverse populations and the need for prospective multicenter external validation before any clinical application. The nomogram may facilitate targeted screening and early intervention for osteoporosis in RA patients, but clinicians should interpret results cautiously until further validation is available.